NCT06560840 Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV
| NCT ID | NCT06560840 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2025-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2024-08-20 with a primary completion date of 2025-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to conduct a dietary intervention targeting HIV specific gut microbiota alterations for primary atherosclerotic cardiovascular disease (ASCVD) prevention and evaluate its effectiveness in preventing ASCVD among older people living with HIV (PLWH).
Eligibility Criteria
Inclusion Criteria: 1. HIV-infected patients diagnosed according to the diagnostic criteria of China AIDS diagnosis and treatment guidelines; 2. Aged 40 years and above; 3. at risk of CVD: having any two of those risk factors: dyslipidemia, DM or elevated blood glucose, smoking, hypertention or elevated blood pressure, metabolic syndrome,overweight/obesity; or PCE score\>5%, 4. Those with a predicted survival time of \>1 year; 5. No plans to leave the depth in the next 3 months; 6. Voluntary participation in this study and signing the informed consent Exclusion Criteria: 1. Those with a previous history of CVD; 2. Those with HIV-related neurocognitive impairment, Alzheimer's disease or dementia, and a variety of serious opportunistic infections; 3. Currently suffering from malignant tumors, gastrointestinal diseases; People with an aversion to eating; 4. Allergic to nuts and fish; 5. People who take medicinal calcium \>1000 mg per day or omega-3 supplements; 6. Plan to become pregnant within 6 months; 7. Are participating in other HIV-related or dietary intervention-related scientific research programs.
Contact & Investigator
Hongzhou Lu, Dr
STUDY DIRECTOR
Shenzhen Third People's Hospital
Frequently Asked Questions
Who can join the NCT06560840 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06560840 currently recruiting?
Yes, NCT06560840 is actively recruiting participants. Contact the research team at 13320178333@163.com for enrollment information.
Where is the NCT06560840 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT06560840 clinical trial?
NCT06560840 is sponsored by Fudan University. The principal investigator is Hongzhou Lu, Dr at Shenzhen Third People's Hospital. The trial plans to enroll 110 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.